Patient Preferences throughout the Medical Product Lifecycle

Chiara Lauren Whichello

Patient Preferences throughout the Medical Product Lifecycle

Chiara Lauren Whichello

Health Technology Assessment (HTA)

Research output: Types of Thesis › Doctoral Thesis › Internal

52 Downloads (Pure)

Original language	English
Awarding Institution	Erasmus University Rotterdam
Supervisors/Advisors	van Molken, Maureen, Supervisor Grob, Esther, Co-supervisor
Award date	9 Dec 2020
Place of Publication	Rotterdam
Publisher	Erasmus Universiteit Rotterdam (EUR)
Print ISBNs	9789080748705
Publication status	Published - 9 Dec 2020

Bibliographical note

The research reported in this thesis was financially supported by The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA

Access to Document

phd-thesis-propositions-v4.pdfOther version, 89.3 KB

Cite this

@phdthesis{c28d03438a24433c8a6374178b38aa0c,

title = "Patient Preferences throughout the Medical Product Lifecycle",

author = "Whichello, \{Chiara Lauren\}",

note = "The research reported in this thesis was financially supported by The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA",

year = "2020",

month = dec,

day = "9",

language = "English",

isbn = "9789080748705",

publisher = "Erasmus Universiteit Rotterdam (EUR)",

school = "Erasmus University Rotterdam",

}

TY - BOOK

T1 - Patient Preferences throughout the Medical Product Lifecycle

AU - Whichello, Chiara Lauren

N1 - The research reported in this thesis was financially supported by The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA

PY - 2020/12/9

Y1 - 2020/12/9

M3 - Doctoral Thesis

SN - 9789080748705

PB - Erasmus Universiteit Rotterdam (EUR)

CY - Rotterdam

ER -